Skip to main content

Advertisement

Table 1 Summary of clinical and pathologic characteristics of the 50 primary melanoma

From: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Breslow thickness (mm), range, SD 4,71 (0,25-24,00)(±3,98)
 ≤1,00 4 (8)
 1,00-2,00 7 (14)
 2,01–4,00 18 (36)
 > 4,00 21 (42)
Histological subtype
 SSM 20 (40)
 NM 20 (40)
 ALM 1 (2)
 LMM 1 (2)
 Unclassified 8 (16)
Anatomic distribution
 Trunk 21 (42)
 Head and neck 9 (18)
 Extremities 20 (40)
Stage at diagnosis
 IB 4 (8)
 IIA 10 (20)
 IIB 12 (24)
 IIC 12 (24)
 IIIA 3 (6)
 IIIB 5 (10)
 IV 4 (8)
Specific histopathological restrictions
 ulceration 24 (48)
 regression 4 (8)
 solar elastosis 8 (16)
 association with a coexistent naevus 4 (8)
Gender
 Male 34 (68)
 Female 16 (32)
Age at surgery (years), range, SD 53 (22–81) (±16,14)
  < 50 20 (40)
  ≥ 50 30 (60)
DNA concentration (ng/ul), SD 134,61 (±115,54)
OS (month), range, SD 45 (1–144) (±35,64)
Tumor content (%), SD 79,1 (±20,14)
  1. Abbreviations: ALM acrolentiginous melanoma, LMM lentigo maligna melanoma, NM nodular melanoma, OS overall survival, SD standard deviation, SSM superficial spreading melanoma